ArticleClinical cancer research : an official journal of the American Association for Cancer Research2019

Phase I and Pharmacology Study of Ropidoxuridine (IPdR) as Prodrug for Iododeoxyuridine-Mediated Tumor Radiosensitization in Advanced GI Cancer Undergoing Radiation.

Timothy Kinsella et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.